Early cardiovascular involvement in chronic obstructive pulmonary disease.

作者: M. Malerba , G. Romanelli

DOI: 10.4081/MONALDI.2009.362

关键词:

摘要: Cardiovascular (CV) disease represents a considerable risk factor in terms of both morbidity and mortality elderly patients with chronic obstructive pulmonary (COPD). In fact, there is evidence this association: for only 20 years forced expiratory volume 1 second (FEV1) has been considered as predictive cardiovascular especially patients. At present, the emerging suggests that hypoxia, systemic inflammation, oxidative stress may cause an early sub-clinical involvement COPD. Aging selective process dramatically affecting certain portions system example: diminished beta-adrenergic responsiveness, increased myocardial vascular stiffness, decreased arterial baroreflex, vagal outflow compromission diastolic function. The nature these interactions complex involves not mechanisms aging but also multiple defined undefined (e.g., genetic) factors. diseases are main causes among subjects impaired lung Even mild reductions flow volumes amplify ischemic heart diseases, strokes, sudden cardiac deaths 2-to 3-fold, independent other mechanism or responsible association, however, remain largely unknown.

参考文章(58)
Àlvar Agusti, Joan B. Soriano, COPD as a Systemic Disease COPD: Journal of Chronic Obstructive Pulmonary Disease. ,vol. 5, pp. 133- 138 ,(2008) , 10.1080/15412550801941349
Peter A McCullough, Judd E Hollander, Richard M Nowak, Alan B Storrow, Philippe Duc, Torbjørn Omland, James McCord, Howard C Herrmann, Philippe G Steg, Arne Westheim, Cathrine Wold Knudsen, William T Abraham, Sumant Lamba, Alan HB Wu, Alberto Perez, Paul Clopton, Padma Krishnaswamy, Radmila Kazanegra, Alan S Maisel, None, Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Academic Emergency Medicine. ,vol. 10, pp. 198- 204 ,(2003) , 10.1197/AEMJ.10.3.198
Shinji Teramoto, Masaki Ishii, Aging, the Aging Lung, and Senile Emphysema Are Different American Journal of Respiratory and Critical Care Medicine. ,vol. 175, pp. 197- 198 ,(2007) , 10.1164/AJRCCM.175.2.197
Frans H. Rutten, Maarten-Jan M. Cramer, Jan-Willem J. Lammers, Diederick E. Grobbee, Arno W. Hoes, Heart failure and chronic obstructive pulmonary disease: An ignored combination? European Journal of Heart Failure. ,vol. 8, pp. 706- 711 ,(2006) , 10.1016/J.EJHEART.2006.01.010
Don D Sin, SF Paul Man, Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality Proceedings of the American Thoracic Society. ,vol. 2, pp. 8- 11 ,(2005) , 10.1513/PATS.200404-032MS
Toru Nyunoya, Martha M. Monick, Aloysius Klingelhutz, Timur O. Yarovinsky, Jeffrey R. Cagley, Gary W. Hunninghake, Cigarette Smoke Induces Cellular Senescence American Journal of Respiratory Cell and Molecular Biology. ,vol. 35, pp. 681- 688 ,(2006) , 10.1165/RCMB.2006-0169OC
Peter M.A. Calverley, Julie A. Anderson, Bartolome Celli, Gary T. Ferguson, Christine Jenkins, Paul W. Jones, Julie C. Yates, Jørgen Vestbo, Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. The New England Journal of Medicine. ,vol. 356, pp. 775- 789 ,(2007) , 10.1056/NEJMOA063070
T. Minamino, S. Kourembanas, Mechanisms of Telomerase Induction During Vascular Smooth Muscle Cell Proliferation Circulation Research. ,vol. 89, pp. 237- 243 ,(2001) , 10.1161/HH1501.094267
Don D Sin, S.F Paul Man, Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Canadian Journal of Physiology and Pharmacology. ,vol. 83, pp. 8- 13 ,(2005) , 10.1139/Y04-116